Cargando…

Circulating Tumor Biomarkers in Meningiomas Reveal a Signature of Equilibrium Between Tumor Growth and Immune Modulation

Meningiomas are primary central nervous system (CNS) tumors that originate from the arachnoid cells of the meninges. Recurrence occurs in higher grade meningiomas and a small subset of Grade I meningiomas with benign histology. Currently, there are no established circulating tumor markers which can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Erkan, Erdogan Pekcan, Ströbel, Thomas, Dorfer, Christian, Sonntagbauer, Markus, Weinhäusel, Andreas, Saydam, Nurten, Saydam, Okay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795693/ https://www.ncbi.nlm.nih.gov/pubmed/31649887 http://dx.doi.org/10.3389/fonc.2019.01031

Ejemplares similares

Antibody Profiling and In Silico Functional Analysis of Differentially Reactive Antibody Signatures of Glioblastomas and Meningiomas
por: Milchram, Lisa, et al.
Publicado: (2023)

miRNA signature of schwannomas: Possible role(s) of “tumor suppressor” miRNAs in benign tumors
por: Erkan, Erdogan Pekcan, et al.
Publicado: (2011)

Deficiency of Ku Induces Host Cell Exploitation in Human Cancer Cells
por: Saydam, Okay, et al.
Publicado: (2021)

SRPX Emerges as a Potential Tumor Marker in the Extracellular Vesicles of Glioblastoma
por: Ampudia-Mesias, Elisabet, et al.
Publicado: (2022)

Genetically Engineered Microvesicles Carrying Suicide mRNA/Protein Inhibit Schwannoma Tumor Growth
por: Mizrak, Arda, et al.
Publicado: (2013)

miR-1289 and “Zipcode”-like Sequence Enrich mRNAs in Microvesicles
por: Bolukbasi, Mehmet Fatih, et al.
Publicado: (2012)

Ape1 guides DNA repair pathway choice that is associated with drug tolerance in glioblastoma
por: Ströbel, Thomas, et al.
Publicado: (2017)

Extracellular-Vesicle-Based Cancer Panels Diagnose Glioblastomas with High Sensitivity and Specificity
por: Mut, Melike, et al.
Publicado: (2023)

Human RECQ5β helicase promotes strand exchange on synthetic DNA structures resembling a stalled replication fork
por: Kanagaraj, Radhakrishnan, et al.
Publicado: (2006)

Specific gene expression signatures of low grade meningiomas
por: Tsitsikov, Erdyni N., et al.
Publicado: (2023)

Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients
por: Chan, Hiu Ting, et al.
Publicado: (2023)

Activation of gene expression by metal-responsive signal transduction pathways.
por: Adams, Timothy K, et al.
Publicado: (2002)

Circulating Tumor Cells: A Promising Biomarker in the Management of Nasopharyngeal Carcinoma
por: Wu, Jiangtao, et al.
Publicado: (2021)

PET/MR Imaging of Somatostatin Receptor Expression and Tumor Vascularity in Meningioma: Implications for Pathophysiology and Tumor Outcomes
por: Roytman, Michelle, et al.
Publicado: (2022)

Evaluation of circulating tumor DNA as a prognostic biomarker for metastatic pancreatic adenocarcinoma
por: Guan, Shasha, et al.
Publicado: (2022)

An Integrative Analysis of Meningioma Tumors Reveals the Determinant Genes and Pathways of Malignant Transformation
por: Iglesias Gómez, José Carlos, et al.
Publicado: (2014)

Circulating Tumor Cells in Desmoid Tumors: New Perspectives
por: Braun, Alexcia C., et al.
Publicado: (2021)

Circulating Tumor Cell and Metabolites as Novel Biomarkers for Early-Stage Lung Cancer Diagnosis
por: Wan, Lingling, et al.
Publicado: (2021)

Application of Circulating Tumor DNA as a Biomarker for Non-Small Cell Lung Cancer
por: Yang, Jialiang, et al.
Publicado: (2021)

Cell-free circulating tumor RNAs in plasma as the potential prognostic biomarkers in colorectal cancer
por: Jin, Nana, et al.
Publicado: (2023)

Clinical diagnostic biomarker “circulating tumor cells” in breast cancer - a meta-analysis
por: Bai, Shiyan, et al.
Publicado: (2023)

Circulating tumor biomarkers in early-stage breast cancer: characteristics, detection, and clinical developments
por: Qiu, Jie, et al.
Publicado: (2023)

Circulating Tumor Cells for Glioma
por: Zhang, Huikai, et al.
Publicado: (2021)

Circulating Tumor DNA Mutations in Progressive Gastrointestinal Stromal Tumors Identify Biomarkers of Treatment Resistance and Uncover Potential Therapeutic Strategies
por: Ko, Tun Kiat, et al.
Publicado: (2022)

Gene Expression Signatures Identify Biologically Homogenous Subgroups of Grade 2 Meningiomas
por: Zador, Zsolt, et al.
Publicado: (2020)

Circulating Tumor DNA as a Prognostic Biomarker in Localized Non-small Cell Lung Cancer
por: Peng, Muyun, et al.
Publicado: (2020)

Analysis of the Equilibrium Phase in Immune-Controlled Tumors Provides Hints for Designing Better Strategies for Cancer Treatment
por: Atsou, Kevin, et al.
Publicado: (2022)

Circulating Tumor Cells: Back to the Future
por: Gallerani, Giulia, et al.
Publicado: (2017)

Mitochondria dysfunction in circulating tumor cells
por: Agnoletto, Chiara, et al.
Publicado: (2022)

Subclinical cardiovascular disease and utility of coronary artery calcium score
por: Saydam, Cihan Durmuş
Publicado: (2021)

Addendum and Corrigendum to “Subclinical cardiovascular disease and utility of coronary artery calcium score” [IJC Heart Vasculat. 37 (2021) 100909]
por: Saydam, Cihan Durmuş
Publicado: (2023)

A Clinical Semantic and Radiomics Nomogram for Predicting Brain Invasion in WHO Grade II Meningioma Based on Tumor and Tumor-to-Brain Interface Features
por: Li, Ning, et al.
Publicado: (2021)

Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival
por: Amantini, Consuelo, et al.
Publicado: (2019)

Evaluation of Cell Surface Vimentin Positive Circulating Tumor Cells as a Diagnostic Biomarker for Lung Cancer
por: Xie, Xiaohong, et al.
Publicado: (2021)

Circulating tumor cells in peripheral blood as a diagnostic biomarker of breast cancer: A meta-analysis
por: Jin, Tao, et al.
Publicado: (2023)

High Tumor Mitochondrial DNA Content Correlates With an Improved Patient's Outcome in WHO Grade III Meningioma
por: Hua, Lingyang, et al.
Publicado: (2020)

Canine Primary Intracranial Cancer: A Clinicopathologic and Comparative Review of Glioma, Meningioma, and Choroid Plexus Tumors
por: Miller, Andrew D., et al.
Publicado: (2019)

TERT Alterations Predict Tumor Progression in De Novo High-Grade Meningiomas Following Adjuvant Radiotherapy
por: Deng, Jiaojiao, et al.
Publicado: (2021)

Pro-metastatic and mesenchymal gene expression signatures characterize circulating tumor cells of neuroblastoma patients with bone marrow metastases and relapse
por: Loh, Amos H. P., et al.
Publicado: (2022)

Mutational signature of extracranial meningioma metastases and their respective primary tumors
por: Biczok, A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_thf0k1qfsuhfg2tr2d82rfdhq5